We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
(+11%)
Cap. Flow
+$734M
Cap. Flow
% of AUM
2.83%
Top 10 Holdings %
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$25.4M |
| 2 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$22.8M |
| 3 |
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
|
+$22.2M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$21.2M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$25M |
| 2 |
First Trust Value Line Dividend Fund
FVD
|
+$22.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.2M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.99% |
| 2 | Financials | 5.01% |
| 3 | Consumer Discretionary | 4.04% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Spear Alpha ETF
SPRX
$240M
| $409K | ﹤0.01% |
+17,450
| New | +$410K |
|
2452
Amplify Online Retail ETF
IBUY
$125M
| $408K | ﹤0.01% |
7,027
-383
| -5% | -$20.6K |
|
2453
Loews
L
$23B
| $408K | ﹤0.01% |
5,211
-13,894
| -73% | -$1.03M |
|
2454
Teledyne Technologies
TDY
$31.2B
| $408K | ﹤0.01% |
950
-59
| -6% | -$25.3K |
|
2455
Repligen
RGEN
$9.45B
| $407K | ﹤0.01% |
2,212
+127
| +6% | +$24.2K |
|
2456
Willis Towers Watson
WTW
$31B
| $406K | ﹤0.01% |
1,478
-184
| -11% | -$48.4K |
|
|
ALTM
2457
DELISTED
Arcadium Lithium plc
ALTM
| $405K | ﹤0.01% |
+93,891
| New | +$471K |
|
2458
Brookfield Infrastructure Partners
BIP
$18.4B
| $404K | ﹤0.01% |
12,939
-332
| -3% | -$10.1K |
|
2459
Ionis Pharmaceuticals
IONS
$9.28B
| $404K | ﹤0.01% |
9,312
-1,722
| -16% | -$82.1K |
|
2460
Iovance Biotherapeutics
IOVA
$2.95B
| $404K | ﹤0.01% |
+27,260
| New | +$317K |
|
2461
Alliance Resource Partners
ARLP
$3.2B
| $403K | ﹤0.01% |
20,118
+345
| +2% | +$7.03K |
|
2462
Global X Blockchain & Bitcoin Strategy ETF
BITS
$23M
| $403K | ﹤0.01% |
+5,485
| New | +$320K |
|
2463
Kymera Therapeutics
KYMR
$9.51B
| $403K | ﹤0.01% |
10,014
+1,000
| +11% | +$35.8K |
|
2464
iShares Inflation Hedged Corporate Bond ETF
LQDI
$69.7M
| $403K | ﹤0.01% |
15,399
+110
| +0.7% | +$2.85K |
|
2465
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.23B
| $403K | ﹤0.01% |
7,851
+1,178
| +18% | +$59.9K |
|
2466
Agilysys
AGYS
$3.25B
| $401K | ﹤0.01% |
+4,755
| New | +$384K |
|
2467
Dimensional Emerging Markets High Profitability ETF
DEHP
$453M
| $401K | ﹤0.01% |
16,138
+2,804
| +21% | +$67.5K |
|
2468
Ferguson
FERG
$48B
| $401K | ﹤0.01% |
1,838
+134
| +8% | +$26.7K |
|
2469
CGI
GIB
$15.5B
| $401K | ﹤0.01% |
+3,631
| New | +$406K |
|
2470
Rogers Corp
ROG
$2.46B
| $401K | ﹤0.01% |
+3,379
| New | +$395K |
|
2471
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$207M
| $400K | ﹤0.01% |
6,176
-5,382
| -47% | -$343K |
|
|
GMS
2472
DELISTED
GMS Inc
GMS
| $400K | ﹤0.01% |
4,105
-659
| -14% | -$57.6K |
|
|
KEEL
2473
Keel Infrastructure Corp
KEEL
$2.04B
| $398K | ﹤0.01% |
178,377
+2,930
| +2% | +$7.62K |
|
2474
CareTrust REIT
CTRE
$9.18B
| $398K | ﹤0.01% |
16,341
-3,656
| -18% | -$82.5K |
|
2475
AdvisorShares Pure US Cannabis ETF
MSOS
$934M
| $398K | ﹤0.01% |
39,744
+11,366
| +40% | +$99.5K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
- Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
- Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
- Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
- Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
- Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
- Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.